Page 4 - Public Issue News Today

Gold can be a good diversifier for most portfolios. SGB can be used to achieve long-term exposure to gold in a tax-efficient manner.

The company received approval from markets regulator Sebi to launch an IPO in April. The company has received a final observation letter for its public offer. In Sebis parlance, an observation letter is equivalent to an approval for the public issue.

SAMHI Hotels Ltd has fixed the price band at Rs 119 to Rs. 126 per Equity Share for its maiden public offer.

Mercury Securities Group Berhad to Raise RM39.27 Million from IPO

Mercury Securities Group Berhad to Raise RM39.27 Million from IPO

Investors participated in the pre-IPO round include SBI Magnum Childrens Benefit Fund, SBI Optimal Equity Fund, SBI Healthcare Opportunities Fund, Neuberger Berman Emerging Markets Equity Fund, Neuberger Berman Europe Holdings LLC and Neuberger Berman Strategic India Equity Master Fund Holdings Ltd.

Mumbai: Non-banking financial company (NBFC) Vivriti Capital Ltd on today announced its first public issue of non-convertible debentures (NCDs) on Friday (Aug 18) to raise up to Rs 500 crore.

The portion reserved for qualified institutional buyers (QIB) was subscribed 68 times, while the non-institutional investors portion was subscribed 17 times. Retail investors bid for 3.78 times the shares set aside for them.

Ahmedabad-based Concord Biotech has fixed the price band at Rs 705 to Rs 741 per Equity Share for its maiden public offer. The initial public offering of the company will open on Friday, 4th August, 2023, for subscription and will close on Tuesday, 8th August 2023. Investors can bid for a minimum of 20 Equity Shares and in multiples of 20 Equity Shares thereafter, , Concord Biotech IPO, price band, stock exchange, pharma news

PFC NCD is a public issue of bonds. It is an investment opportunity for 3 years, 10 years and 15 years.